Mohamed Ali Ahmed

Mohamed Ali Ahmed

Auto-generated profile, based on publicly available information

Mohamed Ali Ahmed

Department of Cardiothoracic Surgery, Faculty of Medicine, Tanta University, Tanta, Egypt

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2022 in The Cardiothoracic Surgeon
Verified
Journal Article
Open access
PDF file
MAMohamed Ali Ahmed
Mohamed Ali Ahmed
AGAhmed Emadeldeen Ghoneim
Ahmed Emadeldeen Ghoneim
AWAmr Abdel Elmonem Abdel Wahab
Amr Abdel Elmonem Abdel Wahab
AMAlaa Basiouni Mahmoud
Alaa Basiouni Mahmoud
Background: Postoperative atrial fibrillation (POAF) occurs within 1 to 5 days after coronary artery bypass grafting (CABG), with a peak occurrence on the second day. This research aimed to assess the role of dose-low amiodarone in the prevention of POAF after CABG. Methods: This randomized controlled blind-single study was carried out on 150 patients undergoing elective CABG with sinus rhythm. Cases were randomized into two equal groups. The placebo group received matching placebo tablets. The amiodarone group received a prophylactic oral amiodarone 5 mg/kg/day for 6 days before and 6 days after surgery. Results: The incidence of POAF was significantly lower in the amiodarone group compared to the placebo group (16% vs 33.3%, P = 0.013) with a relative risk of 0.48 times (95% confidence interval: 0.26–0.88). The onset of POAF, percent of patients responded to medication, and time elapsed to respond to medication were insignificantly different between both groups. The mean (± SD) of ICU stay was 2.51 ± 1.11 days in the amiodarone group versus 3.31 ± 1.83 days in the placebo group, and the mean (± SD) of hospital stay duration was 10 ± 1.99 days in the amiodarone group versus 12.72 ± 2.23 days in the placebo group. The length of ICU admission and hospital stay was significantly lower in the amiodarone group than in the placebo group (P = 0.002 and < 0.001, respectively). Conclusions: Low-dose oral amiodarone was effective in POAF prevention after CABG with a lower length of ICU admission and hospital stay. Trial registration: Pan African Clinical Trials Register PACTR202101651961317. Registered on 21 January 2021

12 August 2026 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
MAMohamed Ahmed
Mohamed Ahmed
MAMohammed Y. Alamassi
Mohammed Y. Alamassi
AYAyman F. Yousef
Ayman F. Yousef
MIMohammed S. Ishaq
Mohammed S. Ishaq
AEAhmed Gamal Elkhouly
Ahmed Gamal Elkhouly
Mohamed Ahmed, M.D., Ph.D.1,2, Mohammed Y. Alamassi, M.D.2, Ayman F. Yousef, M.D.2, Mohammed S. Ishaq, M.D.2, Ahmed Gamal Elkhouly, M.D., Ph.D.1,2. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.26.076